Skip to main content
Clinical Trials/ACTRN12615000144516
ACTRN12615000144516
Completed
Phase 4

Effect of Vitamin D and Omega-3 Fatty Acid Supplements on behavioural measures in Children with Autism Spectrum Disorder (ASD): A randomised, double-blind, placebo-controlled trial

Massey University0 sites119 target enrollmentFebruary 16, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Autism spectrum disorder
Sponsor
Massey University
Enrollment
119
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2015
End Date
August 15, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Medical diagnosis of autism spectrum disorder, onset after 18 months of age; Medical diagnosis of autism spectrum disorder, onset after 18 months of age

Exclusion Criteria

  • Children with winter 25(OH)D concentration \> 75 nmol/L (\+10 nmol/L assay variation) and summer 25(OH)D concentration \> 105 nmol/L (\+10 nmol/L assay variation) at baseline; Children with winter 25(OH)D concentration \> 75 nmol/L (\+10 nmol/L assay variation) and summer 25(OH)D concentration \> 105 nmol/L (\+10 nmol/L assay variation) at baseline

Outcomes

Primary Outcomes

Not specified

Similar Trials